2023-08-04 06:50:57 ET
- Hikma Pharmaceuticals press release ( OTCPK:HKMPF ): 1H GAAP EPS of $59.30.
- Revenue of $1.43B (+18.2% Y/Y).
For further details see:
Hikma Pharmaceuticals GAAP EPS of $59.30, revenue of $1.43Bhome / stock / hkmpf / hkmpf news
2023-08-04 06:50:57 ET
For further details see:
Hikma Pharmaceuticals GAAP EPS of $59.30, revenue of $1.43BMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Hikma Pharmaceuticals Plc Company Name:
HKMPF Stock Symbol:
Market:
Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals Canada NewsWire LONDON , April 29, 2022 /CNW/ -- Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary ...
Hikma resumes launch of generic Advair Diskus® PR Newswire LONDON , April 20, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has resumed the launch of its generic version of ...
LONDON , Sept. 3, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the District of Nevada finding that Hikma's gen...